🇺🇸 FDA
Patent

US 10420769

Methods and compositions for inhibition of polymerase

granted A61KA61K31/196A61K31/215

Quick answer

US patent 10420769 (Methods and compositions for inhibition of polymerase) held by BioCryst Pharmaceuticals, Inc. expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/196, A61K31/215, A61K31/351, A61K31/519